scPharmaceuticals Inc.
SCPHDelisted Oct 7, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001604950
scPharmaceuticals Inc. was delisted on Oct 7, 2025; its insiders filed their last Form 4 on Oct 7, 2025; 110 institutions reported holding it in 13F filings for Q3 2025, worth $232.3M in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding scPharmaceuticals Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 38 | 31 | −7 |
| Shares | 16.0M | 16.2M | +201.2K (+1.3%) |
| Value | $97.9M | $107.9M | +$10.0M (+10.2%) |
New holders (2)
Institutions that held scPharmaceuticals Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| State Street Corp | 14,000 | $93.0K | 0.00% |
| Envestnet Asset Management Inc | 10,696 | $71.0K | 0.00% |
Sold out (9)
Institutions that held scPharmaceuticals Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Russell Investments Group, Ltd. | 194,238 | $1.19M |
| Goldman Sachs Group Inc | 115,264 | $704.0K |
| DAFNA Capital Management LLC | 38,891 | $238.0K |
| First Trust Advisors LP | 23,614 | $144.0K |
| Two Sigma Advisers, LP | 11,000 | $67.0K |
| JPMorgan Chase & Co | 3,174 | $19.0K |
| Tower Research Capital LLC (TRC) | 2,112 | $13.0K |
| New York State Common Retirement Fund | 50 | $0 |
| Captrust Financial Advisors | 39 | $0 |